AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Subsidiary Partners With LUNR Aerospace to Advance AI-Driven Space Medicine
Fifty 1 Labs (OTC: FITY) announced that its subsidiary, Fifty 1 AI Labs, has entered into a partnership with LUNR Aerospace to develop AI-driven drug repurposing initiatives for space medicine. The collaboration will address key health challenges in microgravity, including immune support, musculoskeletal resilience, neuro-ocular protection, cardiovascular stability, cognitive performance, sleep optimization and metabolic longevity. Pilot programs will test AI-curated therapeutics and nutraceuticals in space-relevant conditions, offering a cost-efficient path to innovation. With the global space medicine market projected to grow from USD 948.7 million in 2025 to USD 1.97 billion by 2032 at an 11% CAGR, the partnership positions…